Biotherapeutic manufacturing has been improved significantly in terms of productivity and controllability of Critical Quality Attributes (CQA), but fully controllable, scalable, and intensified biomanufacturing is still a distance target.
The team is developing and validating a mammalian cell culture system with an integrated continuous USP platform for maximum productivity and closed-loop control of CQA. The new intensified biomanufacturing platform will deliver:
The development of a closed design cell culture perfusion system will provide the industry with a fully controllable, scalable, and intensified solution that enables continuous biomanufacturing.
Create a prototype perfusion system for future cGMP implementation.
Demonstrate advanced control of productivity and CQA during specific stages of continuous operation.
Produce an economically-optimized perfusion operation in a production bioreactor.
Implement an intensified continuous biomanufacturing platform.
This project integrated a continuous upstream cell culture platform that increases productivity for drug companies, resulting in cost benefits across mammalian cell culture.
Microfluidic cell retention device building
Integration of hardware and software system
Perfusion system with media recycle
Utilize EK filter for separating lactate and product while retaining most media components
Demonstration of CHO productivity and CQA control implementation
Lee, J., Song, S., Park, Do., Wynne, E., Rajendran, A., Han, J., Yoon, S., & Yamanaka, H., (2025), Continuous Nonoclonal Antibody Production Using Media Recycle in Perfusion, Biotechnology and Bioengineering
Wynne, E., Yoon, J., Park, D., Cui, M., Morris, C., Lee, J., Wang, Z., Yoon, S., & Han, J. (2024). Regeneration of Spent Culture Media for Sustainable and Continuous mAb Production via Ion Concentration Polarization. Biotechnology and Bioengineering. https://doi.org/10.1002/bit.28888
Lee, J., Yoon, S., Participant, Tuscon, AZ, ECI Cell Culture Engineering, April 27, 2025.
Park, D., Wynne, E., Lee, J., Bertalan, T., Han, J., Yoon, S., Wang, Z., Song, S., Yamanaka, H., & Rajendran, A., Integrated Continuous USP Platform for Maximum Productivity and Closed-loop Controlled CQA, NIIMBL National Meeting, Washington, DC, June 24, 2024.
Lee, J., Yoon, S., Speakers, Bioprocess International Boston 2025, Boston, MA September 15, 2025.
Lee, J., Yoon, S., Speakers, Boston, MA American Institute of Chemical Engineering (AIChE) Annual Meeting, November 3, 2025
Lee, J., Yoon, S., Speakers, Integrated Continuous Bioprocessing VII, Croatia, October 6, 2025.
Park, D., Bevacqua, A., Lee, J., Wang, Z., Yoon, S., & Han, J., High-throughput microfluidic cell retention device for perfusion culture, 2023 Bioprocess International, Boston, MA, September 21, 2023.
Wynne, E., Park, D., Yoon, J., Cui, M., & Han, J., High-throughput Electrokinetic Filter for CHO media Regeneration, MicroTAS 2023, Katowice, Poland, November 14, 2023.
Yoon, S., Integrated USP Platform Process, NIIMBL National Meeting 2023, Washington, DC, June 26, 2023.
Login to the NIIMBL member portal to access additional project information, including presentations, progress updates, reports, and more.
Not yet a member? Learn more about which level of NIIMBL membership is right for you and your organization.

University of Massachusetts System
Massachusetts Institute of Technology
Massachusetts Life Sciences Center
Pfizer, Inc.
Whirlcell LLC.
Yokogawa Corporation Of America